Robert J. Gil

Showing 1-9 of 9 articles

Author Taku Asano

Coronary interventions

Treatment with a dedicated bifurcation sirolimus-eluting cobalt-chromium stent for distal left main coronary artery disease: rationale and design of the POLBOS LM study

Asano T, Kogame N, Onuma Y, Modolo R, Chichareon P, Lefèvre T, Legutko J, Digne F, Morel M-A, Serruys P, Gil R

September 24, 2019 | 10.4244/EIJ-D-19-00361

Author Dobrin Vassilev

Intracoronary electrocardiogram to guide percutaneous interventions in coronary bifurcations – a proof of concept: the FIESTA (Ffr vs. IcEcgSTA) study

Vassilev D, Dosev L, Collet C, Karamfiloff K, Stoikova J, Pancheva R, Shumkova M, Zlatancheva G, Naunov V, Rigatelli G, Kassab G, Gil R, Serruys P

August 3, 2018 | 10.4244/EIJ-D-17-00189

Author Robert J. Gil

Coronary interventions

Regular drug-eluting stents versus dedicated bifurcation drug-eluting BiOSS® stents for coronary bifurcation treatment: four-year results of randomized POLBOS I and POLBOS II clinical trials.

Gil R, Bil J, Kern A, Garcia LA, Formuszewicz R, Dobrzycki S, Vassilev D, Segiet A

May 8, 2018 | 10.4244/EIJ-D-18-00172

Author Robert J. Gil

Coronary interventions

Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial

Gil R, Bil J, Grundeken M.J, Kern A, Iñigo Garcia L, Vassilev D, Pawłowski T, Formuszewicz R, Dobrzycki S, Wykrzykowska J, Serruys P

December 9, 2016 | 10.4244/EIJY15M11_11

Author Robert J. Gil

Coronary interventions

Long-term effectiveness and safety of the sirolimus-eluting BiOSS LIM® dedicated bifurcation stent in the treatment of distal left main stenosis: an international registry

Gil R, Bil J, Grundeken M.J, Iñigo Garcia L, Vassilev D, Kern A, Pawłowski T, Wykrzykowska J, Serruys P

November 20, 2016 | 10.4244/EIJY15M10_05

Author Maik J. Grundeken

Coronary interventions

Dedicated stents for distal left main stenting

Grundeken M.J, Magro M, Gil R, Briguori C, Sardella G, Berland J, Wykrzykowska J, Serruys P

May 19, 2015 | 10.4244/EIJV11SVA29

Author Robert J. Gil

Coronary interventions

The BiOSS stent

Gil R, Bil J, Vassilev D

May 19, 2015 | 10.4244/EIJV11SVA37

Author Robert J. Gil

Dedicated paclitaxel-eluting bifurcation stent BiOSS® (bifurcation optimisation stent system): 12-month results from a prospective registry of consecutive all-comers population

Gil R, Vassilev D, Michalek A, Kern A, Formuszewicz R, Dobrzycki S, Wójcik J, Lesiak M, Kardaszewicz P, Lekston A

July 27, 2012 | 10.4244/EIJV8I3A50

Author Dobrin Vassilev

Bifurcation Optimisation Stent System (BiOSS Lim) with sirolimus elution: results from porcine coronary artery model

Vassilev D, Gil R, Milewski K

September 30, 2011 | 10.4244/EIJV7I5A98

1

Latest news

TAVR in sarcopaenia; CCTA or TEE in LAAC; Iintravascular lithotripsy, read the new issue

(CT scans of a sarcopaenic patient)

October 18, 2019

Medical device regulation in Europe – what is changing and how can I become more involved?

October 18, 2019

New this week: Hydrodynamic function with the ALLEGRA heart valve

October 15, 2019

Guidelines, consensus & position papers

When is it best to stop aspirin and who could ultimately benefit?

Aspirin-free antiplatelet regimens after PCI

October 9, 2019

Last week's JAA's: 3D printing in TAVI, QFR SYNTAX score and non-obstructive disease

October 8, 2019

The EuroIntervention health check 2019

October 4, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke